Related Experiment Videos
Mortality-associated factors in infected lymphoma patients
Insights
Patients with non-Hodgkin's lymphoma (NHL) face higher infection-related mortality than those with Hodgkin's lymphoma (HL). Risk factors for NHL mortality include specific infection sites and low blood cell counts.
Area of Science:
- Oncology
- Infectious Diseases
- Hematology
Background:
- Lymphoma, a cancer of the lymphatic system, significantly increases patient susceptibility to infections.
- Infection remains a major cause of mortality in lymphoma patients, necessitating identification of risk factors.
- Previous studies have highlighted infection risks, but specific correlations with mortality in different lymphoma subtypes require further elucidation.
Purpose of the Study:
- To analyze factors associated with infection-related mortality in patients diagnosed with Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL).
- To identify specific clinical and laboratory parameters that predict mortality in lymphoma patients experiencing infections.
- To establish a risk factor profile for infection-associated mortality to aid in clinical management.
Main Methods:
- Retrospective analysis of 388 medical records of patients with lymphoma diagnosed between 1971 and 1980.
- Categorization of patients into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) groups.
- Statistical correlation analysis to identify factors associated with infection-related mortality, including infection site, blood cell counts, and therapy.
Main Results:
- Infection occurred in 100 patients (36 HL, 64 NHL), with overall infection-associated mortality of 17% for HL and 52% for NHL.
- For NHL, mortality correlated significantly with respiratory tract, blood, or multiple-site infections, granulocytopenia, thrombocytopenia, and cytotoxic therapy.
- For HL, mortality correlated only with staphylococcal infections and monocytopenia.
Conclusions:
- Non-Hodgkin's lymphoma patients exhibit a substantially higher risk of mortality from infections compared to Hodgkin's lymphoma patients.
- Specific infection sites and hematological factors like granulocytopenia and thrombocytopenia are critical predictors of mortality in NHL.
- Identifying these risk factors allows for the development of targeted strategies to improve clinical management and outcomes for high-risk lymphoma patients.
Abstract:
Three hundred eighty-eight medical records of patients with lymphoma seen between 1971 and 1980 were analyzed for factors related to infection-associated mortality. Infection occurred in 100 patients (36 Hodgkin's lymphoma [HL], and 64 non-Hodgkin's lymphoma [NHL]). The overall mortality with infection was 17% (6 of 36) for HL and 52% (33 of 64) for NHL. In patients with NHL mortality correlated with infection in the respiratory tract (P less than or equal to 0.0001), blood (P less than or equal to 0.003), and multiple sites (P less than or equal to 0.0004) and with the following factors: granulocytopenia (P less than or equal to 0.05), thrombocytopenia (P less than or equal to 0.035), and cytotoxic therapy (P less than or equal to 0.034). Patients with HL showed a positive correlation only with staphylococcal infections (P less than or equal to 0.001) and monocytopenia (P less than or equal to 0.01). The above data may be used to generate a risk factor profile of patients at greater risk of mortality associated with such infections. Advance knowledge of such a profile may assist in the clinical management of these high-risk patients.